CN Patent

CN114040782A — 跨鼓膜递送平台及其用途

Assigned to Medical College of Wisconsin · Expires 2022-02-11 · 4y expired

What this patent protects

本文提供了用于将治疗剂如抗微生物剂、抗炎剂和抗生物膜剂跨鼓膜递送到中耳,用于快速、局部治疗和预防与中耳感染相关的疾病和病症的方法和组合物。具体地,本文提供了基于聚合物、阳离子和阴离子的纳米颗粒,其提供了用于递送治疗性载物部分的平台,以及用于快速、局部递送治疗剂至中耳的基于聚合物、阳离子和阴离子的纳米颗粒组合物。

USPTO Abstract

本文提供了用于将治疗剂如抗微生物剂、抗炎剂和抗生物膜剂跨鼓膜递送到中耳,用于快速、局部治疗和预防与中耳感染相关的疾病和病症的方法和组合物。具体地,本文提供了基于聚合物、阳离子和阴离子的纳米颗粒,其提供了用于递送治疗性载物部分的平台,以及用于快速、局部递送治疗剂至中耳的基于聚合物、阳离子和阴离子的纳米颗粒组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114040782A
Jurisdiction
CN
Classification
Expires
2022-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Medical College of Wisconsin
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.